documents: FDA-2020-D-1136-0056

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-D-1136-0056 FDA FDA-2020-D-1136 Development of Abbreviated New Drug Applications During the COVID-19 Pandemic – Questions and Answers - Guidance for Industry - April 2021 U.S. Department of Health and Human Services Food and Drug Administration Center for Other Guidance 2021-04-07T04:00:00Z 2021 4 2021-04-07T04:00:00Z 2023-05-12T03:59:59Z 2023-05-08T18:53:55Z   0 0 0900006484a9f1b6

Links from other tables